- Product NDC
- 66096-723
- 11-digit product format
- 660960723
- Labeler code
- 66096
- Product ID
- 66096-723_d44b323b-0822-b3d4-e053-2995a90aafb7
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Argentum nitricum, Astragalus menziesii, Calcarea sulphurica, Cuprum arsenicosum, DNA, Ferrum phosphoricum, Kali muriaticum, Kali sulphuricum, Ledum palustre, Magnesia phosphorica, RNA, Silicea.
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- OHM PHARMA INC.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2017-11-20
- Substance
- ASTRAGALUS NUTTALLII LEAF; CALCIUM SULFATE ANHYDROUS; CUPRIC ARSENITE; FERROSOFERRIC PHOSPHATE; HERRING SPERM DNA; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM CHLORIDE; POTASSIUM SULFATE; RHODODENDRON TOMENTOSUM LEAFY TWIG; SACCHAROMYCES CEREVISIAE RNA; SILICON DIOXIDE; SILVER NITRATE
- Active strength
- 3; 6; 12; 6; 4; 6; 6; 6; 1; 4; 6; 6 [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_C]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_M]/59mL; [hp_C]/59mL; [hp_X]/59mL; [hp_X]/59mL
- Pharmacologic classes
- Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes